• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏肾计量评分是肾实质年生长率的一个预测因素。

RENAL nephrometry score is a predictive factor for the annual growth rate of renal mass.

作者信息

Matsumoto Ryuji, Abe Takashige, Shinohara Nobuo, Murai Sachiyo, Maruyama Satoru, Tsuchiya Kunihiko, Nonomura Katsuya

机构信息

Department of Urology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

出版信息

Int J Urol. 2014 Jun;21(6):549-52. doi: 10.1111/iju.12388. Epub 2014 Jan 9.

DOI:10.1111/iju.12388
PMID:24405437
Abstract

OBJECTIVE

To evaluate the association between the RENAL nephrometry score and annual growth rates of renal masses presumed to be renal cell carcinoma.

METHODS

The current study included 47 renal tumors followed up for at least 12 months, of which 26 tumors were found to be pathologically proven renal cell carcinomas. Annual tumor growth rates were calculated from changes in the maximal diameter on computed tomography, and RENAL nephrometry scores were recorded on initial imaging by two senior urologists. The associations between clinical characteristics including the RENAL nephrometry score and annual growth rates were analyzed using a linear regression model.

RESULTS

The median tumor size at diagnosis was 1.7 cm (range 0.6-5.8). The median nephrometry score at diagnosis was 7 (range 4-10). Overall, the median tumor growth rate was 0.34 cm per year (range -0.19-2.0). Linear regression analysis showed that the annual tumor growth rate was associated with the RENAL nephrometry score (P < 0.0001), but it was independent of the age at diagnosis, sex and initial tumor size. In addition, the correlation between the RENAL nephrometry score and annual growth rate remained significant in the 26 pathologically proven renal cell carcinomas.

CONCLUSIONS

The RENAL nephrometry score is associated with the annual growth rate of renal masses. Our findings further support the association between the RENAL nephrometry score and tumor biology.

摘要

目的

评估RENAL肾计量评分与疑似肾细胞癌的肾肿块年生长率之间的关联。

方法

本研究纳入了47例随访至少12个月的肾肿瘤,其中26例经病理证实为肾细胞癌。根据计算机断层扫描上最大直径的变化计算肿瘤年生长率,并由两名资深泌尿外科医生在初始影像学检查时记录RENAL肾计量评分。使用线性回归模型分析包括RENAL肾计量评分在内的临床特征与年生长率之间的关联。

结果

诊断时肿瘤的中位大小为1.7 cm(范围0.6 - 5.8)。诊断时肾计量评分的中位数为7(范围4 - 10)。总体而言,肿瘤的中位生长率为每年0.34 cm(范围 - 0.19 - 2.0)。线性回归分析显示,肿瘤年生长率与RENAL肾计量评分相关(P < 0.0001),但与诊断时的年龄、性别和初始肿瘤大小无关。此外,在26例经病理证实的肾细胞癌中,RENAL肾计量评分与年生长率之间的相关性仍然显著。

结论

RENAL肾计量评分与肾肿块的年生长率相关。我们的研究结果进一步支持了RENAL肾计量评分与肿瘤生物学之间的关联。

相似文献

1
RENAL nephrometry score is a predictive factor for the annual growth rate of renal mass.肾脏肾计量评分是肾实质年生长率的一个预测因素。
Int J Urol. 2014 Jun;21(6):549-52. doi: 10.1111/iju.12388. Epub 2014 Jan 9.
2
R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.R.E.N.A.L.(半径、外生性/内生性、与集合系统或肾窦的接近程度、前后位以及相对于极线的位置)肾计量评分可预测肾细胞癌经皮消融治疗后的早期肿瘤复发和并发症:5年经验
J Vasc Interv Radiol. 2015 May;26(5):686-93. doi: 10.1016/j.jvir.2015.01.008. Epub 2015 Mar 11.
3
Renal tumour nephrometry score does not correlate with the risk of radiofrequency ablation complications.肾肿瘤肿瘤学评分与射频消融并发症风险无关。
BJU Int. 2013 Dec;112(8):1121-4. doi: 10.1111/bju.12276.
4
The performance of a modified RENAL nephrometry score in predicting renal mass radiofrequency ablation success.改良的RENAL肾计量评分在预测肾肿物射频消融成功率方面的表现。
Urology. 2015 Jan;85(1):125-9. doi: 10.1016/j.urology.2014.08.026. Epub 2014 Oct 18.
5
The initial experience with RENAL Nephrometry in children, adolescents, and young adults with renal tumors.儿童、青少年和青年肾肿瘤患者的 RENAL 分数初始经验。
Pediatr Blood Cancer. 2014 Aug;61(8):1434-9. doi: 10.1002/pbc.25027. Epub 2014 Mar 9.
6
Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors.R.E.N.A.L. 肾脏肿瘤解剖评分系统对 751 例经皮消融肾脏肿瘤的疗效及并发症预测价值。
J Urol. 2013 Jan;189(1):30-5. doi: 10.1016/j.juro.2012.08.180. Epub 2012 Nov 16.
7
External validation of a nomogram using RENAL nephrometry score to predict high grade renal cell carcinoma.基于 RENAL 评分的列线图预测高级别肾细胞癌的外部验证。
J Urol. 2012 May;187(5):1555-60. doi: 10.1016/j.juro.2011.12.099. Epub 2012 Mar 14.
8
A multidisciplinary evaluation of inter-reviewer agreement of the nephrometry score and the prediction of long-term outcomes.多学科评估肾肿瘤评分的组内一致性及其对长期预后的预测价值。
J Urol. 2011 Oct;186(4):1223-8. doi: 10.1016/j.juro.2011.05.052. Epub 2011 Aug 17.
9
Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar.在监测下,肾细胞癌和嗜酸细胞瘤的生长速率相似。
Urol Oncol. 2007 Mar-Apr;25(2):115-9. doi: 10.1016/j.urolonc.2006.07.018.
10
Robot-assisted laparoscopic nephron sparing surgery for tumors over 4 cm: operative results and preliminary oncologic outcomes from a multicentre French study.机器人辅助腹腔镜肾部分切除术治疗 4cm 以上肿瘤:一项来自法国多中心研究的手术结果和初步肿瘤学结果。
Eur J Surg Oncol. 2013 Jul;39(7):799-803. doi: 10.1016/j.ejso.2013.03.007. Epub 2013 Apr 6.

引用本文的文献

1
Kidney scoring surveillance: predictive machine learning models for clear cell renal cell carcinoma growth using MRI.肾脏评分监测:使用 MRI 预测透明细胞肾细胞癌生长的机器学习模型。
Abdom Radiol (NY). 2024 Apr;49(4):1202-1209. doi: 10.1007/s00261-023-04162-y. Epub 2024 Feb 12.
2
The kidney imaging surveillance scoring system (KISSS): using qualitative MRI features to predict growth rate of renal tumors in patients with von-Hippel Lindau (VHL) syndrome.肾脏影像监测评分系统(KISSS):利用 MRI 定性特征预测 von-Hippel Lindau(VHL)综合征患者肾肿瘤的生长速度。
Abdom Radiol (NY). 2024 Feb;49(2):542-550. doi: 10.1007/s00261-023-04087-6. Epub 2023 Nov 27.
3
An MRI-based radiomics model to predict clear cell renal cell carcinoma growth rate classes in patients with von Hippel-Lindau syndrome.
基于 MRI 的放射组学模型预测 von Hippel-Lindau 综合征患者透明细胞肾细胞癌的生长率类别。
Abdom Radiol (NY). 2022 Oct;47(10):3554-3562. doi: 10.1007/s00261-022-03610-5. Epub 2022 Jul 22.
4
Evaluation of the Clinical Use of Robot-Assisted Retroperitoneal Laparoscopy and Preoperative RENAL Scoring for Nephron Sparing Surgery in Renal Tumor Patients.机器人辅助腹膜后腹腔镜手术及术前RENAL评分在肾肿瘤患者保留肾单位手术中的临床应用评估
Indian J Surg. 2018 Jun;80(3):252-258. doi: 10.1007/s12262-016-1572-0. Epub 2016 Dec 26.
5
R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy.R.E.N.A.L.肾计量评分可预测接受根治性肾切除术治疗的局限性肾细胞癌的术后复发情况。
Int J Clin Oncol. 2016 Apr;21(2):367-372. doi: 10.1007/s10147-015-0879-3. Epub 2015 Jul 29.